NOT KNOWN FACTUAL STATEMENTS ABOUT WHAT ARE THE BEST NEUROPROTECTIVE DRUGS?

Determined by the subgroup Evaluation, we located that there was substantial heterogeneity concerning mortality, favorable outcomes, and the full treatment method successful price. Relating to mortality, the reason for heterogeneity on the subgroup of edaravone dexborneol and EDV was mostly attributed to differences in drug dosage. With regards to